NLRP3 and Hyperglycemia: In diabetes, persistent hyperglycemia and metabolic dysregulation lead to chronic NLRP3 activation in pancreatic β-cells, adipose tissue, and vasculature, thereby fueling systemic inflammation and insulin resistance (Chen S. et al., 2025; Delalat, et al., 2025).